Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review

<b>Objective:</b> To review the efficacy and safety of reduced dose compared to standard dose Enzalutamide treatment for patients with castration-resistant prostate cancer (CRPC). <b>Methods:</b> PubMed, Scopus, Web of Science, and Cochrane databases were searched for randomi...

Full description

Saved in:
Bibliographic Details
Main Authors: Zineddine Belabaci, Lucas Mose, Omar El-Taji, Zina Otmani, Zein Alabdin Hannouneh, Issa Mohamad, Thomas Zilli, Osama Mohamad, Nadeem Pervez, Waleed Arafat, Ursula Vogl, Mohamed Shelan
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/5/732
Tags: Add Tag
No Tags, Be the first to tag this record!